Jabbal-Gill I - Search Results

1

Jabbal-Gill I. Jabbal-Gill I. J Drug Target. 2010 Dec;18(10):771-86. doi: 10.3109/1061186X.2010.523790. J Drug Target. 2010. PMID: 21047271 Review.

2

Chitosan as a novel nasal delivery system for vaccines.

Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Illum L, et al. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5. Adv Drug Deliv Rev. 2001. PMID: 11516781 Review.

3

Chitosan-based delivery systems for mucosal vaccines.

Jabbal-Gill I, Watts P, Smith A. Jabbal-Gill I, et al. Expert Opin Drug Deliv. 2012 Sep;9(9):1051-67. doi: 10.1517/17425247.2012.697455. Epub 2012 Jun 19. Expert Opin Drug Deliv. 2012. PMID: 22708875 Review.

4

Polymeric lamellar substrate particles for intranasal vaccination.

Jabbal-Gill I, Lin W, Kistner O, Davis SS, Illum L. Jabbal-Gill I, et al. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):97-111. doi: 10.1016/s0169-409x(01)00173-9. Adv Drug Deliv Rev. 2001. PMID: 11516782 Review.

5

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.

Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L. Jabbal-Gill I, et al. Vaccine. 1998 Dec;16(20):2039-46. doi: 10.1016/s0264-410x(98)00077-2. Vaccine. 1998. PMID: 9796062

6

Effective nasal influenza vaccine delivery using chitosan.

Read RC, Naylor SC, Potter CW, Bond J, Jabbal-Gill I, Fisher A, Illum L, Jennings R. Read RC, et al. Among authors: jabbal gill i. Vaccine. 2005 Aug 15;23(35):4367-74. doi: 10.1016/j.vaccine.2005.04.021. Vaccine. 2005. PMID: 15916838

7

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.

Jabbal-Gill I, Lin W, Jenkins P, Watts P, Jimenez M, Illum L, Davis SS, Wood JM, Major D, Minor PD, Li X, Lavelle EC, Coombes AG. Jabbal-Gill I, et al. Vaccine. 1999 Sep;18(3-4):238-50. doi: 10.1016/s0264-410x(99)00195-4. Vaccine. 1999. PMID: 10506648

8

Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Illum L. Dyer AM, et al. Pharm Res. 2002 Jul;19(7):998-1008. doi: 10.1023/a:1016418523014. Pharm Res. 2002. PMID: 12180553

9

Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.

Cheng YH, Dyer AM, Jabbal-Gill I, Hinchcliffe M, Nankervis R, Smith A, Watts P. Cheng YH, et al. Among authors: jabbal gill i. Eur J Pharm Sci. 2005 Sep;26(1):9-15. doi: 10.1016/j.ejps.2005.03.014. Eur J Pharm Sci. 2005. PMID: 15970435

10

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

Svindland SC, Pedersen GK, Pathirana RD, Bredholt G, Nøstbakken JK, Jul-Larsen Å, Guzmán CA, Montomoli E, Lapini G, Piccirella S, Jabbal-Gill I, Hinchcliffe M, Cox RJ. Svindland SC, et al. Among authors: jabbal gill i. Influenza Other Respir Viruses. 2013 Nov;7(6):1181-93. doi: 10.1111/irv.12056. Epub 2012 Nov 21. Influenza Other Respir Viruses. 2013. PMID: 23170900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page